In the case of hypoxic conditions usually seen in patients with COVID-19, the effect of IL-10 on macrophages can be altered and cause an increase in pro-inflammatory cytokines like IL-6 via the activation of the hypoxia-inducible factor (HIF) pathway [48]. This evidence concerns the gene IL10 and COVID-19.